VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
JANX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
JANXJanux Therapeutics, Inc.
$17.63$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksJANXQuarterly Cash Flow

Janux Therapeutics, Inc. (JANX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Janux Therapeutics, Inc. (JANX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

JANX Cash Flow Statement

Quarterly statement

JANX Cash Flow Statement

Janux Therapeutics, Inc. (JANX) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-25.18M12.48M-12.34M-28.54M-12.86M-23.81M-17.02M-16.73M-2.23M-10.02M-14.84M-9.9M-11.71M-15.05M-13.91M-11.91M-13.41M-6.07M-11.52M-10.48M
Operating CF Margin %-271.09%121.59%-330.48%--128.56%----508.2%-112.63%-1185.06%-402.32%-465.2%-1424.22%-679.25%-418.73%-739.88%-256.79%-725.11%-648.58%
Operating CF Growth %-95.88%152.43%27.53%-70.65%-476.24%-137.63%-14.74%-68.92%80.95%33.43%-6.66%16.89%12.71%-147.88%-20.73%-13.66%-129.14%2.11%-307.12%-543.4%
Net Income-21.57M-21.97M-24.36M-31.95M-24.31M-33.86M-23.51M-20.22M-28.06M-5.96M-14.76M-11.76M-11.57M-17.51M-17.46M-16.07M-16.7M-16.89M-13.41M-13.42M
Depreciation & Amortization458K463K469K468K501K541K519K512K510K506K532K531K500K471K453K403K249K108K81K64K
Stock-Based Compensation8.54M9.06M9.27M9.52M9.04M10.96M10.7M6.25M15.39M5.76M5.63M4.48M4.55M5.5M5.47M4.21M4.6M4.44M3.96M2.94M
Deferred Taxes00000000000000000000
Other Non-Cash Items-3.33M-2.89M-2.62M-3.52M-4.62M-5.21M-4.22M-2.93M-2.9M-2.97M-1.79M-2.06M-2.11M-1.84M-1.68M-1.29M-768K-99K-24K-58K
Working Capital Changes-9.28M27.82M4.91M-3.06M6.54M3.75M-516K-345K12.83M-7.35M-4.45M-1.1M-3.08M-1.68M-700K836K-795K6.36M-2.13M-15K
Change in Receivables-262K34.85M-35M000000-6.98M-519K00750K-750K500K-500K000
Change in Inventory00000000000000000000
Change in Payables1.28M-342K-1.61M1.67M-168K1.11M-1.64M1.56M1.18M-694K-456K327K228K-171K-107K223K-634K857K-740K-482K
Cash from Investing38.38M-38.78M8.29M29.54M8.31M1.56M-340.39M33.93M12.67M-190.88M-113.74M11.12M-61.45M17.87M-8.74M-1.6M19.76M9.04M31.07M7.33M
Capital Expenditures-2K-202K-273K-106K-93K-473K-371K-42K-25K-95K-197K-515K-470K-580K-285K-2.06M-2.52M-898K-971K-1.17M
CapEx % of Revenue0.02%1.97%7.31%-0.93%---5.69%1.07%15.73%20.93%18.67%54.87%13.92%72.27%139%37.97%61.11%72.59%
Acquisitions00000000000-11.64M60.98M000-22.28M000
Investments--------------------
Other Investing0000000000011.64M-60.98M00022.28M000
Cash from Financing852K2.24M3.54M2.94M493K954K554K386.65M1.65M2.77M322.17M831K56.61M528K1.58M191K0308K1K164K
Debt Issued (Net)00000000000000000000
Equity Issued (Net)852K2.24M3.54M2.94M493K954K554K378.21M1.65M-455K320.51M831K56.53M01.58M00308K1K164K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing00000008.44M03.22M1.66M079K528K0191K0000
Net Change in Cash14.05M-24.06M-506K3.94M-4.06M-21.3M-356.86M403.85M12.09M-198.14M193.6M2.05M-16.55M3.35M-21.07M-13.33M6.35M3.27M19.55M-3.81M
Free Cash Flow-25.18M12.28M-12.61M-28.65M-12.95M-24.29M-17.39M-16.77M-2.26M-10.12M-15.03M-10.42M-12.18M-15.63M-14.2M-13.97M-15.93M-6.97M-12.49M-11.65M
FCF Margin %-271.12%119.63%-337.8%--129.49%----513.9%-113.7%-1200.8%-423.24%-483.87%-1479.09%-693.16%-491%-878.87%-294.76%-786.22%-721.16%
FCF Growth %-94.49%150.57%27.51%-70.86%-473.98%-140.08%-15.7%-60.97%81.48%35.29%-5.9%25.43%23.57%-124.27%-13.63%-19.86%-168.66%-10.95%-330.92%-615.41%
FCF per Share-0.400.20-0.20-0.46-0.21-0.39-0.28-0.31-0.04-0.19-0.31-0.22-0.27-0.37-0.34-0.34-0.38-0.17-0.30-0.28
FCF Conversion (FCF/Net Income)1.17x-0.57x0.51x0.89x0.53x0.70x0.72x0.83x0.08x1.68x1.01x0.84x1.01x0.86x0.80x0.74x0.80x0.36x0.86x0.78x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000